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SMOKING GUN:




In the debate over medical marijuana, the primary justifica-
tion advanced by its supporters is that marijuana use, especially by
terminally ill patients, mitigates their "suffering from [unnecessary]
chronic and unbearable pain that persists until death."' Currently,
Washington D.C. and fourteen states have approved and finalized
medical marijuana statutes: Alaska, California, Colorado, Hawaii,
Maine, Michigan, Montana, Nevada, New Jersey, New Mexico, Ore-
gon, Rhode Island, Vermont, and Washington. 2 Maryland and Ari-
zona have approved legislation favorable to the use of medical mari-
juana, but have not legalized its use. Additionally, "New York,
. J.D. Candidate, 2011, Touro College Jacob D. Fuchsberg Law Center. I would like to
thank Dean Louise Harmon for her invaluable guidance and encouragement, the editors of
the Touro Law Review for the opportunity to publish my work, and my family, friends, and
girlfriend Lauren for all of their love, understanding, and support.
1 Jay M. Zitter, Annotation, Construction and Application of Medical Maryuana Laws
and Medical Necessity Defense to Maryuana Laws, 50 A.L.R.6th 353 (2009).
2 14 Legal Medical Maryuana States and DC: Laws, Fees, and Possession Limits,
PROCON.ORG, http://medicalmarijuana.procon.org/view.resource.php?resourcelD=000881
(last updated Aug. 24, 2010).
3 Id. See Maryland Darrell Putman Compassionate Use Act, MD. CODE ANN., CRIM. LAW
§ 5-601(c)(3)(ii) (West 2010) (mitigating consequences if an individual possesses marijuana
for medical use). With an overwhelming bipartisan support, Maryland's Senate approved
the bill by a 35-12 margin without any objections or discussion. Ryan Grim, Medical Mari-
juana Bill Moves Through Maryland Senate in Landslide, HUFFINGTON POST (Apr. 10, 2010,
4:20 PM), http://www.huffingtonpost.com/2010/04/10/medical-marijuana-bill-
mo n_532962.html. Senator David Brinkley (R-Frederick), the bill's sponsor and a two-
time cancer survivor, stated "Anyone who has watched a loved one suffer from a debilitat-
ing illness would agree that we should not stand between doctors and patients, or deprive
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Illinois, Delaware, South Dakota, ... and Kansas" are in the process
of considering medical marijuana laws.4
Although all patients should have the right to treatment,
rights, generally, must be considered within the context of national
policy. Currently, the federal government has remained hesitant to
support detailed medical research and advocacy for medical marijua-
na.5  Under the Uniform Controlled Substances Act, marijuana re-
mains a Schedule I drug, meaning possession of it is still illegal and
may only be utilized for research purposes.6 As "the sole Federal
agency that approves drug products as safe and effective for in-
tended" purposes, the Federal Drug Administration ("FDA") firmly
maintains that marijuana has no medicinal value.7 Consequently, the
federal government has been in continuous conflict with states that
have legalized medical marijuana.8
According to the American Medical Association, when a phy-
sician believes a law is unjust, he or she should work to change the
4 Grim, supra note 3. As of 2009, The Medical Society of the State of New York adopted
an affirmative policy that:
[T]he use of marijuana may be appropriate when prescribed by a li-
censed physician solely for use in alleviating pain and nausea in patients
who have been diagnosed as chronically ill with life threatening disease,
when all other treatments have failed, that the physicians who prescribe
marijuana for patient use, subject to the conditions set forth above, shall
not be held criminally, civilly or professionally liable and that it supports
continued clinical trails [sic] on the use of marijuana for medical purpos-
es.
MSSNY Position Statements, 75.987 Medical Marijuana, MED. SOC'Y OF THE STATE OF N.Y.,
http://www.mssny.org/mssnyip.cfm?c=i&nm=Drugs_%7CMedications (last visited Oct.
11,2010).
See Paul Armentano, Why Isn't There More Medical Marituana Research? Because The
Feds Won't Allow It, That's Why!, NORML BLOG (Jan. 27, 2010),
http://blog.norml.org/2010/01/27/why-isnE2%80%99t-there-more-medical-marijuana-
research-because-the-feds-won%E2%80%99t-allow-it-that%E2%80%99s-why/.
6 21 U.S.C.A. § 812(b)(1) (West 2010).
Press Release, FDA, Inter-Agency Advisory Regarding Claims That Smoked Marijuana
Is a Medicine (Apr. 20, 2006), available at http://www.fda.gov/NewsEvents/Newsroom/Pre
ssAnnouncements/2006/ucm 1 08643.htm.
8 See ALASKA STAT. § 17.37.010 (2010); HAW. REV. STAT. § 329-123(b) (2010); ME. REV.
STAT. tit. 22, § 2425 (2010); MICH. COMP. LAWS § 333.26424 (2010); MONT. CODE ANN. §
50-46-103 (2010); NEV. REV. STAT. § 453A.050 (2010); N.J. STAT. ANN. § 24:61-4 (West
2010); N.M. STAT. ANN. § 26-21-4(D) (2010); ORE. REv. STAT. § 475.309(2)(a) (2010); R.I.
GEN. LAWS § 21-28.6-4 (2010); VT. STAT. ANN. tit. 18, § 4473 (2010); WASH. REV. CODE §
69.5 1A.005 (2010).
2
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law. 9 If medical marijuana is one treatment a physician can prescribe
to alleviate a patient's pain and suffering, then the physician must
promote the best interests of the patient by maintaining his or her
well being and health.' 0 Ultimately, the federal government's prohi-
bition on access to and use of medical marijuana to alleviate pain in
terminally ill patients infringes upon their autonomy, which includes
their rights to live and avoid severe physical suffering, the right to re-
ceive medical treatment, and the right to die with the dignity that
comes from one's own choices." If these patients truly find comfort
by using medical marijuana, the federal government should not deli-
berately deny prolonged pain relieving treatments that improve a
terminally ill patient's quality of life.
Part I will discuss the concept of patient autonomy and its le-
gal corollary, the doctrine of informed consent, as it applies in the
physician-patient relationship. By exploring the philosophy of Im-
manuel Kant and John Stuart Mill, Part I will discuss how the denial
of access to medical marijuana infringes upon a patient's ability to
practice his or her autonomy and pursue adequate healthcare deci-
sions and treatment. Part II will discuss the therapeutic uses and risks
associated with medical marijuana, as well as issues in prescribing
medical marijuana. By tracing the legislative history surrounding the
medical marijuana controversy, Part III will discuss the Uniform
Controlled Substances Act and marijuana's subsequent placement in-
to Schedule I and state legislation legalizing medical marijuana. Fi-
nally, Part IV will discuss patient autonomy and the terminally ill pa-
tients' access to medical marijuana by examining the conflict
between federal and state legislation.
II. PATIENT'S CHOICE: THE PURSUIT OF AUTONOMY
Perhaps no greater principle exists in society than autonomy,
the right to self-determination or self-governance.' 2 An individual
9 AMA Code of Medical Ethics: Principles of Medical Ethics, AM. MED. Ass'N,
http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics
/principles-medical-ethics.shtml (last visited Mar. 12, 2010) [hereinafter Principles of Medi-
cal Ethics].
1O Id.
" Note, Last Resorts and Fundamental Rights: The Substantive Due Process Implications
of Prohibitions on Medical Marijuana, 118 HARV. L. REv. 1985, 1990 (2005) [hereinafter
Last Resorts].
12 BIOMEDICAL ETHIcs 38-39 (Thomas A. Mappes & David DeGrazia eds., 5th ed. 2001).
2011] 341
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makes an autonomous decision when he or she "make[s] the deci-
sions that affect [his or her life] and act[s] on the basis of these deci-
sions."l 3 In order to be truly autonomous, an "individual must act in
a rational manner."l 4 Although autonomy requires a degree of inde-
pendence, an individual must avoid self-deception and irrationality to
reach an informed decision." Choices must be natural inclinations,
not random decisions.16 If an individual follows purely bodily de-
sires, autonomy will be completely lost.' 7
Through a patient's autonomy, a patient should exercise his or
her rational capacity to self-govern and choose a course of action
among different alternatives. For Immanuel Kant, one of the world's
most learned philosophers, the fundamental principle of morality is
respect for persons as moral agents, which includes respect for per-
sonal autonomy. Humans should be respected as self-determining
subjects, or rather, persons, as rational agents, should be treated as
ends in themselves and never mere objects.' 9 For Kant, the individu-
al has the freedom to pursue the principles of a self-legislated ethical
system. 20 While an individual is free to follow his or her personal be-
liefs of what is right, Kant's view of autonomy requires that "rational
self-determination [be made] in accordance with universal moral
laws." 21
Similarly, John Stuart Mill views autonomy in terms of indi-
viduality, which includes individual liberty and personal self-
1 Id. at 39. When a patient provides informed consent, the patient performs a truly auto-
nomous action that is "(1) intentional, (2) based on sufficient understanding, (3) sufficiently
free of external constraints, and (4) sufficiently free of internal constraints." Id
14 Andrew J. Boyd, Medical Marijuana and Personal Autonomy, 37 J. MARSHALL L. REV.
1253, 1280(2004).
15 id.
16 Id. at 1281.
'" Id
1 See M. Hayry, Prescribing Cannabis: Freedom, Autonomy, and Values, 30 J. MED.
ETHICS 333, 334 -35 (2004). Kant believed individuals should celebrate their autonomy be-
cause "it is the only thing that can distinguish [rational beings] from the rest of the world,
and [therefore] make us moral." Id. at 335.
19 Id
20 See JESSICA W. BERG ET AL., INFORMED CONSENT: LEGAL THEORY AND CLINICAL
PRACTICE 22 (2d ed. 2001).
21 See Hayry, supra note 18, at 335. Kant believed that all of mankind, as rational beings,
possesses "morally-practical reason," enabling mankind to be "free to make its own laws,
and to act in accordance with them, without paying unnecessary attention to the demands of
the body. Id. at 334.
[Vol. 27342
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determination. 22  People possessing individuality reach their "deci-
sions without manipulation by others, and exercising firmness and
self-control in acting on their decisions."23 However, Mill followed
the principle of utility, which holds that " 'actions are right in propor-
tion as they tend to promote happiness; wrong as they tend to produce
the reverse of happiness. By happiness is intended pleasure and the
absence of pain; by unhappiness, pain and the privation of plea-
sure.' "924 For Mill, utility was happiness that would be maximized as
long as the individual knew what produced personal happiness and
was allowed to act on that knowledge.25
Individuality, as an expression of reason and will through
one's choices, is extremely valuable to one's sense of self, but both
Kant and Mill would agree that an individual cannot pursue his or her
own happiness at the expense of others.2 6 For Kant, "[t]he morality
of an action . . . must be assessed in terms of the motivation behind
it." 27 But Kant did not mean that an action is morally good based on
its outcome; rational beings should act according to the categorical
imperative, that is, " '[a]ct only according to that maxim by which
you can at the same time will that it should become a universal
law.' "28 Even if a person intends to bring about a beneficial out-
come or effect, an action is morally good only if it is guided by rea-
22 BIOMEDICAL ETHICS, supra note 12, at 43 (describing that pursuant to Mill, individuals
"choos[e] their own plans of life, mak[e] their own decisions without manipulation by oth-
ers, and exercis[e] firmness and self-control in acting on their decisions"). In Mill's work
On Liberty, he stressed the importance of autonomy, stating: "The only freedom which de-
serves the name is that of pursuing our own good in our own way, so long as we do not at-
tempt to deprive others of theirs or impede their efforts to obtain it." BERG ET AL., supra
note 20, at 23.
23 BIOMEDICAL ETHICs, supra note 12, at 43.
24 Colin Heydt, John Stuart Mill, INTERNET ENCYCLOPEDIA PHIL., http://www.iep.utm.edu/
milljs/#SH2d (last updated Oct. 24, 2006). As a consequentialist, Mill believed that the cor-
rectness of an act is dependent on the consequences of the act. See id. Also, Mill followed
utilitarianism, a form of consequentialist ethics, which states the maximization of utility is
the goal of human action, and identifying utility with pleasure, Mill believed that utility was
happiness. See BERG ET AL., supra note 20, at 22-23.
See BERG ET AL., supra note 20, at 22-24.
26 See Heydt, supra note 24 (noting that it is imperative "that we aren't violating the rights
of others"); see also Matt McCormick, Immanuel Kant: Metaphysics, INTERNET
ENCYCLOPEDIA PHIL., http://www.iep.utm.edu/kantmeta/#H8 (last updated June 30, 2005).
Since duty comprises the core of deontological ethics, Kant stressed that ethical obligations
must be fulfilled regardless of the consequences, and thereby, a duty exists independent from
its practical outcome. Id.
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Likewise, under the harm principle, Mill stressed that the
State may only interfere with a competent adult's individual liberty to
prevent direct harm to others. 30 Mill believed that the utility of an ac-
tion is determined by its tendency to produce or promote happiness,
but while "happiness [is] the only intrinsically desirable end," Mill
warned against pursuing only individual happiness. 3' However, an
action does not have to be motivated by seeking the general happi-
ness for all of society to be considered morally right. 32 When an in-
dividual seeks his own happiness, he or she must also consider the
general public's well being, but only to the extent of ensuring that his
or her actions do not "violate[] the rights of others."33
A. Patient-Physician Relationship
While the healthcare industry must abide by the law, a physi-
cian and patient must continue to work towards the promotion of a
patient's autonomy at all costs. 34  At the heart of the patient-
physician relationship, autonomy exists in "the patient's right to re-
29 BIOMEDICAL ETHIcs, supra note 12, at 43. (explaining that an individual's actions must
be based upon effective deliberation, guided by reason, and neither motivated by personal
emotions nor manipulated by others).
30 Heydt, supra note 24.
31 See id. (indicating that although many actions may create both positive and negative
conditions, Mill followed the utilitarian calculation where the right action is one that upon
balancing its positive and negative utility, promotes the most happiness rather than pain).
32 Id. By focusing on the notion of self-determination, Mill believed that three types of
liberty exist: "inward domain of consciousness," in which an individual has the freedom to
have his or her own thoughts and feelings; "liberty of tastes and pursuits," where an individ-
ual has the freedom to define his own existence and live as he or she sees fit; and the "free-
dom to unite with others" in which an individual has the freedom to coexist and combine
with others. See id. Under the harm principle, Mill believed that the State could only inter-
fere with these three individual liberties to protect society from harm caused by an individu-
al's practice of these liberties. Id.
3 See Heydt, supra note 24 (describing that as a utilitarian, Mill focused on the value of
equality in which each individual counts as one, and every individual included in the utilita-
rian calculation counts equally when determining the true right action).
34 See AM. COLL. OF LEGAL MED., LEGAL MEDICINE 223 (Shafeek S. Sanbar ed., 6th ed.
2004) [hereinafter LEGAL MEDICINE] (noting that although autonomy remains a vital aspect
of medicine, it is important to remember that a patient's autonomous decision-making is li-
mited because the "[f]aw is mostly about limits on autonomy"). The importance placed on a
patient's autonomy has resulted from the attitudes of western society, which "put[s] a high
value on free choice and liberty, and thus respect for even foolish or eccentric decisions is
ultimately required because of the perception that the sort of society that does not require
respect for autonomy is profoundly unacceptable." Id.
6
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ceive information sufficient to . . . make an intelligent," reasonable
decision, as well as the patient's right "to accept or refuse the rec-
ommended medical treatment.",3  As a relationship based on trust,
the physician has an "ethical obligation[] to place [the] patient['s]
welfare above [his or her] own self-interest and above obligations to
other groups."36 The physician should serve as an advocate to pro-
mote the patient's welfare above all.
While both patient and physician must take an active role in
the medical decision-making process, both actors have essentially
different roles.38 A competent patient should exert some control over
healthcare decisions, but do so in accordance with certain responsibil-
ities. When choosing medical treatment, a patient should "be truthful
and . . . express [his or her] concerns . . . to [his or her] physician[],"
provide all necessary medical information, and cooperate and comply
with the chosen treatment. 39 Adhering to Mill's harm principle, a pa-
tient may practice his or her autonomy, but should refrain from beha-
vior that unreasonably risks the health of others.40
While the physician must always rely on sound medical
judgment, he or she must keep the patient's bests interests as para-
mount.4 1 "The physician must support the [patient's] dignity. . . and
3 See id; see also GEORGE D. POZGAR, LEGAL AND ETHICAL ISSUES FOR HEALTH
PROFESSIONALS 275 (2005).
Where there are two or more medically acceptable treatment approaches
to a particular medical problem, the informed consent doctrine, medical
ethics, and the standard of care all provide that a competent patient has
the absolute right to select from among these treatment options after be-
ing informed of the relative risks and benefits of each approach.
Id.
Opinion 10.015: The Patient-Physician Relationship, AM. MED. Ass'N,
http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/
opinionl0015.shtml (last visited Mar. 12, 2010) [hereinafter Patient-Physician Relation-
sh * ].
Id.
38 Opinion 10.02: Patient Responsibilities, AM. MED. Ass'N, http://www.ama-
assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinionl002.sht
ml (last visited Oct. 14, 2010) [hereinafter Patient Responsibilities].
SId.
4 Id. (adding that when considering the risks to others and a patient's own well-being, a
patient should assume personal responsibility to practice a healthy lifestyle, avoid the devel-
opment of disease and potential transfer of disease to others).
41 See id.; see also Definition of Hippocratic Oath, MEDTERMS.COM,
http://www.medterms.com/script/main/art.asp?articlekey-20909 (last visited Oct. 16, 2010).
Under the modem version of the Hippocratic Oath, a physician agrees to "apply, for the ben-
2011] 345
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respect [his or her] uniqueness."4 2 In order to provide competent
medical care, the physician should maintain the patient's "right to
courtesy, respect, dignity, responsiveness, and timely attention to his
or her needs." 43 Accordingly, a physician's first duty is to maintain
the patient's health, a duty that should not be sacrificed to avoid
prosecution by the federal government." Since "[a] physician [must]
. . . regard [his or her] responsibility to the patient as paramount,"
"[a] physician shall respect the law and also recognize a responsibili-
ty to seek changes in those requirements which are contrary to the
best interests of the patient." 45  By guiding the patient towards the
optimal course of action, a physician has the obligation to serve as
the patient's advocate and to foster the "patient['s right to] accept or
refuse any recommended medical treatment." 4 6
B. Informed Consent
Under the doctrine of informed consent, the physician, acting
as a rational agent, is directed to respect the patient's freedom and
right to make self-determinations concerning the best course of action
for himself or herself.47 Informed consent "applies only when [a] pa-
tient[] possess[es the necessary competence or] decision-making ca-
pacity."48 "When securing a [competent] patient's permission to ad-
minister treatment," a physician must disclose all necessary
information regarding treatment, including "the nature and duration
of the treatment, the likelihood of success, the likely risks and bene-
fits associated with the recommended treatment, the alternatives (if
any) available to the recommended treatment, and the likely conse-
quences if treatment is refused." 49 After the information has been
efit of the sick, all measures which are required ... . [and] prevent disease whenever [he or
she] can .. .. with special obligations to all [his or her] fellow human beings." Id.
42 POZGAR, supra note 35, at 286.
43 Opinion 10.01: Fundamental Elements of the Patient-Physician Relationship, AM.
MED. Ass'N, http://www.ama-assn.org/amalpub/physician-resources/medical-ethics/code-
medical-ethics/opinionlOOl.shtml (last visited Oct. 14, 2010) [hereinafter Fundamental
Elements].
4 Principles of Medical Ethics, supra note 9.
45 id
46 Fundamental Elements, supra note 43.
47 POZGAR, supra note 35, at 14.
48 TERRANCE C. MCCONNELL, INALIENABLE RIGHTS: THE LIMITS OF CONSENT IN MEDICINE
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disclosed, it is necessary that the patient possess an understanding of
the disclosed material.so Lastly, the physician must receive authori-
zation from the patient to carry out the treatment, "such as [his or her]
signature on a consent form." 5 '
Additionally, the doctrine of informed consent is based on the
physician's "legal, ethical, and moral duty to respect patient autono-
my and to provide only authorized medical treatment." 52  Conse-
quently, the physician has two correlative duties associated with in-
formed consent. First, the physician has a "duty to disclose . . .
appropriate information about risks and alternatives."53 Although pa-
tients have the right to make their own decisions, they can only prac-
tice their autonomy and reach a reasonable decision if they know the
risks, benefits, and alternatives to recommended procedures.5 4 Se-
condly, "[t]he duty to obtain consent requires [that the physician] se-
cur[e] proper patient authorization." 5 Accordingly, the physician
should respect the patient as a fellow rational agent by maintaining
the patient's dignity and well being. 56 By allowing the patient to vo-
luntarily reach a decision, free from pressure or coercion, the physi-
cian ensures that a patient's right of self-determination is maintained
in the pursuit of adequate medical care.
C. Restraints on Patient Autonomy
Under the doctrine of informed consent and the patient-
physician relationship, a patient has the right to effectively choose
medical treatment according to a physician's recommendation in or-
der to preserve an individual's liberty and autonomy.58  When a pa-
tient receives necessary medical treatment, the physician, the patient,
and the healthcare industry have collectively upheld the patient's
"dignity, autonomy, and avoidance of pain."59  When a patient's
mental, emotional, and physical integrity is respected, the patient is
o Id.
51 Id
52 POZGAR, supra note 35, at 275.
5 MCCONNELL, supra note 48, at 65.
54 POZGAR, supra note 35, at 275.
ss MCCONNELL, supra note 48, at 65-66.
56 See Fundamental Elements, supra note 43.
5 See MCCONNELL, supra note 48, at 65.
58 See Last Resorts, supra note 11, at 1995.
' Id. at 1996.
2011] 347
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viewed as a free and equal moral person before others.6 ' However,
this freedom and respect is denied to patients when the federal gov-
ernment deprives terminally ill patients and other deserving unwell
people from obtaining and using medical marijuana, or even being
able to consider it as an option. When all other treatments have prov-
en to be ineffective, both patient and physician can continue to work
to treat the patient's illness and lessen pain and suffering.6 Medical
marijuana, however, is eliminated from this equation.
Although informed consent safeguards the right to determine
one's own destiny, current marijuana regulations only deteriorate the
physician-patient relationship and narrow the importance of informed
consent.62 By exercising its parens patriae power, the federal gov-
ernment attempts to protect the individual and act for the individual's
benefit; however, under the principle of patient autonomy, an indi-
vidual has a right against interference with the ability to control his or
her life.63 In order to choose freely among a variety of options, an
individual must not be constrained by excessive pressure that results
in undue influence or coercion." If medical marijuana effectively al-
leviates pain for a patient, or if the patient believes medical marijuana
is the only effective treatment when all others have failed, the federal
government unduly burdens the patient and coerces him or her to ac-
cept undesirable, perhaps ineffective, treatments. As a result, the
federal government effectively strips individuals of a potentially ef-
fective treatment option.
60 See Canterbury v. Spence, 464 F.2d 772, 780 (D.C. Cir. 1972). Canterbury established
the fundamental principle of informed consent "that '[e]very human being of adult years and
sound mind has a right to determine what shall be done with his own body.' " Id. (alteration
in original) (quoting Schloendorff v. Soc'y of N.Y. Hosp., 105 N.E. 92, 93 (N.Y. 1914)).
61 See Fundamental Elements, supra note 43. Consequently, a patient's freedom and au-
tonomy can be respected and promoted by physicians working with the general public to re-
move economic and social constraints impeding a patient's access to medical treatment.
Hayry, supra note 18, at 334.
62 See BERG ET AL., supra note 20, at 24 ("Autonomy is the freedom from external con-
straints . . . and the capacity for self-determination."). Informed consent considers medical
decision-making a combination between the physician's technical expertise and the patient's
subjective considerations. Id. at 30. Medical decisions cannot belong solely to a physician
because only the patient has access to highly relevant personal information necessary to the
decision. See id.
6 Hayry, supra note 18, at 334. As rational agents, Kant believed that individuals fol-
lowed a "morally-practical reason" in which an individual "is free to make its own laws, and
to act in accordance with them." Id.
6 BERG ET AL., supra note 20, at 25 (indicating that such decisions "severely compromise
the capacity for autonomy").
348 [Vol. 27
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If society seeks to promote autonomy, it must minimize go-
vernmental regulation over the individual's ability to freely choose in
the healthcare context. 65 By recognizing the benefits of medical ma-
rijuana, the federal government can promote the patient's autonomy
by allowing physicians to prescribe medical marijuana "to relieve
suffering, produce beneficial outcomes . .. and enhance the patient's
quality of life."66
II. MARIJUANA AS MEDICINE: FACT OR ILLUSION?
Marijuana has been used medicinally for over five thousand
years, with the earliest accounts dating back to China in the third mil-
lennium, B.C., where it was used to treat malaria and rheumatic
pain.67 "In India, marijuana [was] used in Ayurvedic medicine," as
early as the Tenth Century, to treat various ailments, including "di-
arrhea, diabetes, tuberculosis, asthma, elephantiasis, anemia, and ra-
bies."68 In the Middle East, marijuana's medicinal value was recog-
nized as early as the Seventh Century, B.C., and "during . . the
Roman Empire, marijuana was used as an analgesic and anesthet-
ic."69 In Europe, marijuana was recommended as medicine around
65 A.D. and was used well into the Nineteenth Century.70 In the
United States, physicians recognized marijuana's medicinal value as
early as 1850 by listing it in the United States Pharmacopoeia "as a
65 See Hayry, supra note 18, at 334 ("Legislation obviously plays an important role in
what health professionals can and cannot do.").
66 LEGAL MEDICINE, supra note 34, at 227.
67 RICHARD GLEN BOIRE & KEVIN FEENEY, MEDICAL MARIJUANA LAW 13-14 (2006).
68 Id. at 14. "Marijuana is listed as an ingredient in numerous [medicinal] preparations in
the Anandakanda, a [Tenth] Century Indian Medical treatise, [and] is still used by some
Ayurvedic doctors today." Id.
69 Id. Medical marijuana was mentioned in a Middle Eastern religious text called the Ve-
nidad, which many believe Zoroaster wrote. Id. The Romans later "used [marijuana] to
treat migraines, syphilis[,] and other medical problems." BOIRE & FEENEY, supra note 66, at
14.
70 See id at 14-15. The medicinal use of marijuana in Europe was recommended in sever-
al texts: in 65 A.D., in Dioscoride's Materia Medica, which was considered a fundamental
medical text through the Seventeenth Century; in 1538, in William Turner's New Herbal
which listed marijuana as a therapeutic agent; in 1649, in Nicholas Culpeper's The Complete
Herbal which "recommended marijuana [to] treat[] ... coughs, jaundice, joint pain, inflam-
mation[,] and indigestion"; "in the 1840s ... a French doctor[,] . . . Jacques-Joseph Mo-
reau[,] found that marijuana suppressed headaches, increased appetites, and aided in sleep";
and in the British medical journal, The Lancet, which discussed how marijuana was used to
treat opiate withdrawal. Id.
2011] 349
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treatment for ... neuralgia, tetanus, typhus,... leprosy,... gout,...
insanity,. . . among others."'
Originating from the leaves of the hemp plant, Cannabis Sati-
va, or marijuana, contains over 460 known compounds of which sixty
are unique to marijuana, and are commonly referred to as cannabino-
ids. 72  "Delta-9-tetrahydrocannabinol [("THC")], one of the most
psychoactive ingredients in marijuana," eliminates "[1]oss of appetite,
nausea, and vomiting" in cancer patients undergoing chemotherapy.73
Moreover, while THC may increase feelings of depression, these
symptoms depend largely on the dose, as well as the psychological
and physiological makeup of the patient.74 Most importantly, THC
serves as an analgesic that decreases sensitivity to pain.7 1
A. Medicinal Value
Through a study conducted by the National Institutes of
Health ("NIH") in February 1997, five areas in which medical mari-
juana may provide therapeutic value were identified, though further
research is still required.
1. Wasting Syndrome: Aids and Cancer
Many patients with AIDS (acquired immunodeficiency syn-
drome) or cancer are affected with significant weight loss and de-
creased caloric intake.77 "Symptoms of AIDS wasting syndrome in-
clude an involuntary weight loss of at least ten percent with chronic
diarrhea, weakness, or fever for thirty days or more.. . "7 In order
" Id. at 16. Although a few marijuana distributors existed at this time, such as Parke Da-
vis and E.R. Squibb & Sons, these distributors had problems determining the appropriate
dosage and potency from different plants and processing, a major difficulty that still exists
today. Id.
72 Pharmacodynamics, CREIGHTON UNIV. MED. CTR., http://altmed.creighton.edulmedical
marijuana/Pharmacology.htm (last visited March 12, 2010).
73 Therese Andrysiak et al., Marijuana for the Oncology Patient, 79 AM. J. NURSING 1396,
1396 (1979).
74 See id (suggesting that the patient's personality influences the effects of marijuana).
s id. ("Until the 1930s . .. marijuana was listed in the pharmacopoeia as an analgesic.").
76 See Jane B. Marmor, Commentary, Medical Marijuana, 168 W. J. MED. 540, 541
(1998).
n Id.
78 Annaliese Smith, Comment, Marjuana as a Schedule I Substance: Political Ploy or
Accepted Science?, 40 SANTA CLARA L. REv. 1137, 1162 (2000).
[Vol. 27350
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to achieve weight gain, some of these patients have smoked medical
marijuana to stimulate their appetite and food intake." Additionally,
"inhaled marijuana increases appetite and food intake in healthy per-
sons."80 Since "there are no current cost-effective treatments for the
wasting of AIDS or cancer," medical marijuana may be an appropri-
ate treatment upon further research to determine its safety and effec-
tiveness.81
2. Nausea and Vomiting
For many cancer patients undergoing chemotherapy, the vari-
ous treatments and drugs, such as pharmacologic agents (5-HT 3 re-
ceptor antagonists), often produce side effects of emesis (vomiting
and nausea). 82  Although antiemetic drugs are often prescribed to
cancer patients, these medications often fail to work once emesis de-
velops.83 Since early treatment is the only way to truly deter emesis,
many cancer patients inevitably suffer from such intense side effects
that they forego treatment all together.84 Searching for an alternative
treatment, many cancer patients have smoked medical marijuana to
deter emesis.8 5  Research shows that "THC reduces the number of
retching and vomiting episodes, the degree and duration of nausea,
and the volume of emesis in cancer patients undergoing chemothera-
py." 86
7 See Marmor, supra note 76, at 541.
80 Id.
81 Id
82 Anticipatory Nausea and Vomiting (Emesis), NAT'L CANCER INST.,
http://www.cancer.gov/cancertopics/pdq/supportivecare/nausea/HealthProfessionapage4
(last visited Mar. 18, 2010) [hereinafter NAT'L CANCER INST.]. "[A]nticipatory nausea ap-
pears to occur in approximately 29% of patients receiving chemotherapy (about one of three




85 See Marmor, supra note 76, at 541; see also NAT'L CANCER INST., supra note 82 (indi-
cating that many medication treatments fail; thus, behavioral interventions have been inves-
tigated and suggested for cancer patients suffering from emesis, including: "progressive
muscle relaxation with guided imagery, hypnosis, systematic desensitization, electromyo-
graphy and thermal biofeedback and distraction via the use of video games").6 Smith, supra note 78, at 1162.
2011] 351
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3. Glaucoma
"Glaucoma is a group of diseases that can damage the eye's
optic nerve and result in vision loss and blindness."8 7 "Glaucoma oc-
curs when the normal fluid pressure inside the eyes slowly rises,"
wherein intraocular pressure causes intolerable levels of discomfort. 8
Although patients can protect their eyes against serious vision loss
with early treatment, many glaucoma patients have resorted to smok-
ing medical marijuana in order to relieve the pressure on their eyes.
Although marijuana only provides temporary relief for short dura-
tions, marijuana effectively reduces "intraocular pressure, pupil con-
striction, and conjunctival hyperemia."90
4. Pain and Suffering
Scientists have discovered two cannabinoid receptors, proper-
ly identified as CB 1 and CB2, that "are present widely in the brain"
as part of the human body's natural pain control system.91 Conse-
quently, marijuana performs a therapeutic function that has enabled
cancer patients and patients in general to relieve pain, even if tempo-
rarily. 92 Since many current analgesics are only marginally effective,
cannabinoids may become a superior treatment in pain therapy, but
only after further research is conducted.9 '
5. Neurologic and Movement Disorders
Lastly, the NIH has found evidence of marijuana relieving
neurologic and movement disorders. 94 As an unpredictable disease
with no known cause, "[m]ultiple sclerosis [("MS")] affects the cen-
8 Facts About Glaucoma, NAT'L EYE INST., http://www.nei.nih.gov/health/glaucoma/glau
coma facts.asp (last visited Nov. 8, 2010) [hereinafter NAT'L EYE INST.].
88j -
SId.
89 See Marmor, supra note 76, at 542 (finding "dramatic decreases in intraocular pressure
with smoked marijuana in patients with glaucoma").
90 Smith, supra note 78, at 1162.
Marmor, supra note 76, at 542.
92 See id. at 540 (alleging that marijuana is used to relieve pain for conditions such as
"AIDS . .. arthritis .. . mood disorders ... neurologic symptoms ... cancer .. . [and] glau-
coma").
9 Id. at 542-43 (indicating that several conditions have been identified "for which there
may be a therapeutic benefit from marijuana use and that merit further research").
94 Id. at 542.
352 [Vol. 27
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tral nervous system by damaging nerve fibers," which often results in
muscle spasticity where the muscles become "stiff, inflexible, and
prone to spasms and cramping." 95 While "[m]ost MS patients expe-
rience muscle weakness in their extremities and difficulty with coor-
dination and balance[,]" some patients experience symptoms "severe
enough to impair walking or even standing." 96 "MS can [even] pro-
duce partial or complete paralysis."97 Since no cure or effective me-
dication for MS exists, initial research has revealed that smoking ma-
rijuana has relieved, "spasticity and nocturnal spasms [associated
with] multiple sclerosis and partial spinal cord injury."98
Furthermore, the Institute of Medicine ("IOM"), in a March
1999 study, concluded that marijuana's benefits are limited to symp-
tom relief, such as pain relief, appetite stimulation for AIDS wasting
syndrome, and control of chemotherapy related nausea and vomit-
ing.99 Despite popular belief, the IOM reported that marijuana was
only marginally useful in relieving eye pressure from glaucoma be-
cause the effects were only "short-term, and did not outweigh the
long-term" risks."o Moreover, the report reaffirmed that marijuana
effectively treated "muscle spasms associated with multiple sclero-
sis.""' However, despite these findings, "the IOM advised that mari-
juana [should] be considered . . only when patients [did not receive]
9 Boyd, supra note 14, at 1276.
96 NINDS Multiple Sclerosis Information Page, NAT'L INST. OF NEUROLOGICAL
DISORDERS & STROKE, http://www.ninds.nih.gov/disorders/multiple sclerosis/multiple_scl
erosis.htm (last visited Mar. 15, 2010) [hereinafter Multiple Sclerosis]. "Most people with
MS [experience] ... abnormal sensory feelings such as numbness, prickling, or 'pins and
needles' sensations" and may even suffer from pain. Id. Other common complaints include
"[sipeech impediments, tremors, and dizziness," and some MS patients even experience
hearing loss. Id.
97 Id. ("Approximately half of all people with MS experience cognitive impairments such
as difficulties with concentration, attention, memory, and poor judgment, but such symptoms
are usually mild and are frequently overlooked. Depression is another common feature of
MS.").
9 Marmor, supra note 76, at 542 (referring to a study of ten patients with multiple sclero-
sis who smoked marijuana, which indicated that smoking marijuana "further impairs posture
and balance in [such] patients," but "no large-scale controlled clinical studies have been re-
ported" as of yet).
9 Peter A. Clark, The Ethics of Medical Marituana: Government Restrictions vs. Medical
Necessity, 21 J. PUB. HEALTH POL'Y 40, 40-41 (2000).
'" Id. at 46.
"o' Id. at 41.
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enough relief from currently available drugs."l 02 While the IOM cau-
tioned "that 'the benefits of smoking marijuana were limited by the
toxic effects of the smoke, [the study] nonetheless recommended' "
that patients be permitted to smoke marijuana when other therapies
failed "on a short-term basis under close supervision."' 0 3
B. Common Misconceptions:
Gateway Drug Theory and Addiction
Despite popular belief, the 1M suppressed marijuana critics'
argument that marijuana is a gateway drug and that legalization
would result in increased use among the general population.'04  Al-
though "marijuana use often precedes the use of hard drugs among
abusers," the 1M found there was insufficient evidence to support
the proposition that marijuana use necessarily led the progression to
experimentation with harder drugs.' Also, the New England Jour-
nal of Medicine added that marijuana is not a gateway drug, and
"there is no evidence that use of [marijuana] would increase . . . if
marijuana was legalized for medicinal purposes and regulated like
other medications." 06
Additionally, a major consideration must be placed on the so-
cial environment and behavioral context in which marijuana may be
used. Peer pressure, in addition to a permissive environment, may
lead marijuana users to abuse harder drugs.'0 7 Additionally, the me-
102 See Medical Marituana and the Mind, HARV. MENTAL HEALTH LETTER, Apr. 1, 2010,
available at 2010 WLNR 7099085 [hereinafter HARV. MENTAL HEALTH LETTER]; see also
Clark, supra note 99, at 46.
103 Clark, supra note 99, at 41, 46. While the report urged that alternative delivery me-
thods such as "capsules, patches and bronchial inhalers [be] developed," the IOM realized
such methods may take time to develop, and stated that smoking marijuana could be permit-
ted in the mean time, despite the potential harmful effects of marijuana smoke. Id. at 46.
104 See J. Ryan Conboy, Smoke Screen: America's Drug Policy and Medical Marjuana,
55 FOOD& DRUG L.J. 601, 614-15 (2000).
105 Id.
106 Id at 615. See George J. Annas, Reefer Madness: The Federal Response to Calfor-
nia's Medical-Mariyuana Law, 337 NEw ENG. J. MED. 435, 438 (1997) (referring to a 1994
study that found 83% of then current marijuana users never tried cocaine, and only "17[%]
of current marijuana users [reported that] they had tried cocaine").
107 Peter J. Cohen, Medical Mariuana: The Conflict Between Scientific Evidence and Po-
litical Ideology, 2009 UTAH L. REv. 35, 67 (2009). An Australian study of 311 young adult
identical and non-identical, same-sex twin pairs who began smoking marijuana in their early
teens concluded:
The association [between early marijuana use and later drug use and
[Vol. 27354
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thod of acquiring marijuana plays a significant role in the use of
harder drugs. Unlike heroin or cocaine, marijuana is "more easily
available and less socially stigmatized."' 08 However, since "marijua-
na remains illegal, the only way to acquire [marijuana] for recrea-
tional use is [buying] it from [a dealer who may easily] . . . provide
access to harder drugs."'0o It may be "possible that a person who is
psychologically disposed to seek the recreational enjoyment of mari-
juana is also [psychologically] disposed to seek . .. heroin" or co-
caine for recreational enjoyment."o Consequently, there is a weak
causal connection between the use of marijuana and the subsequent
use of harder drugs.
Also, while tolerance to marijuana often occurs, dependency
on THC does not occur. Although marijuana has a slight addictive
quality, only a mild withdrawal syndrome occurs."' "[T]he risk of
becoming dependent on [marijuana] . .. is more like the risk [asso-
ciated with] alcohol than for [either nicotine or] opioids."" 2 Only
"about [ten] percent of regular marijuana users become addicted";
whereas, addiction arises fifteen percent in alcohol users, thirty-two
percent for nicotine users, and twenty-three percent for opiate us-
ers." 3 Despite their addictive qualities, opiates, such as morphine,
are used significantly in pain therapy; physicians prescribing mor-
abuse or dependence] may arise from the effects of the peer and social
context within which cannabis is used and obtained. In particular, early
access to and use of cannabis may reduce perceived barriers against the
use of other illegal drugs and provide access to these drugs.
Id. at 68 (alteration in original).
108 See DOUGLAS HUSAK & PETER DE MARNEFFE, THE LEGALIZATION OF DRUGS: FOR AND
AGAINST 178-79 (2005) ("The most widely used illegal drug [in America] is marijuana.
Studies indicate ... a third of Americans older than [twelve] years old have tried this drug;
that about [one] in [ten] has used it within the past year; and that [one] in [seventeen] has
used it in the past month.").
109 Cynthia S. Duncan, Note, The Need for Change: An Economic Analysis of Marituana
Policy, 41 CONN. L. REv. 1701, 1707-08 (2009).
110 HUSAK & DE MARNEFFE, supra note 108, at 178-79 (suggesting that evidence indicates
a strong correlation between marijuana use and subsequent use of cocaine and heroin; only a
minority of heroin or cocaine users did not try marijuana first).
1 See Smith, supra note 78, at 1165. Marijuana produces a very limited possibility of
physical addiction and symptoms of "withdrawal syndrome consisting of irritability, res-
tlessness, nervousness, decreased appetite, weight loss, insomnia, rebound increase in REM
sleep, tremor chills, and increased body temperature." Id. However, "[i]f this [marijuana]
withdrawal syndrome occurs, it only lasts four to five days." Id
112 Cohen, supra note 107, at 56.
113 Id.
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phine must carefully consider the possibility of addiction.114 Howev-
er, when the risks and benefits are balanced, even morphine remains
a legalized, yet addictive drug, while marijuana remains sidelined for
prescriptive use.
C. Medical Risks and Prescription Issues
In assessing the medicinal value of any drug for therapeutic
purposes, the benefits must outweigh the risks. The " 'therapeutic ra-
tio,' the difference between the size of dose needed for the desired ef-
fect and the size that produces poisoning," of marijuana has not been
found, however "it has been estimated [to be] in the thousands" due
to the safety of the drug."' In fact, a lethal dose of marijuana has yet
to be calculated."' 6
Whether marijuana is smoked or taken orally, many patients
encounter "a dose-related 'high' usually consisting of a pleasant, eu-
phoric, relaxed feeling of well-being."' 17  A patient may encounter
rapid heartbeat, become anxious or even paranoid, and suffer occa-
sional acute panic. 118 However, "hallucinations are rare, even at
high[er] doses."' 19 Recreational use may also affect cognitive func-
tion, or the thought process, including " 'impairment of the ability to
learn[,] .. . the formation of new memories[,] . . . [d]epersonalization,
and other ... effects' " on social behavior.120 While marijuana may
cause temporary impairment of short-term memory, thinking, and
concentration, the symptoms experienced by the user depend on the
114 Id at 56. It is interesting that the Controlled Substances Act permits the use of mor-
phine, an "indispensable [drug] to modern medical practice [which is also] potentially lethal
. . . . 'Morphine is a primary and continuous depressant of respiration ... [that] is discernible
even with doses too small to disturb consciousness.' " Id. at 54-55.
115 RICHARD LAWRENCE MILLER, THE CASE FOR LEGALIZING DRUGS 19 (1991).
116 Id. Since "[m]arijuana does not create physical resonance, . . . no withdrawal syn-
drome occurs" within the user. Id. Consequently, aspirin likely produces more deaths from
overdose than marijuana. Id.
117 Andrysiak et al., supra note 73, at 1397.
118 See HARv. MENTAL HEALTH LETTER, supra note 102. Although intense anxiety and
panic attacks are the most common side effects of smoking marijuana, "[s]tudies report that
about 20% to 30% of recreational users experience such problems after smoking marijuana,"
and first time users are even more vulnerable to such side effects. Id.
119 Andrysiak et al., supra note 73, at 1397.
120 Cohen, supra note 107, at 58. A recent study found "long-term marijuana users were
impaired [seventy] percent of the time on a decision-making test, compared to [fifty-five]
percent for short-term users and [eight] percent for nonusers." Id. However, there has been
no consensus as to marijuana's long-term cognitive effects. Id at 58-59.
18
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dosage consumed or inhaled.' 2 '
Additionally, while a patient may have difficulty communi-
cating due to short-term memory loss, "[c]oordination and reflex
[skills remain] relatively unaffected." 22 In particular, marijuana im-
pairs a patient's critical skills "such as judgment of distances and
reaction time" necessary to operate a motor vehicle safely.123  Addi-
tionally, there has been no evidence of long-term memory impair-
ment.124 "Studies suggest that although overall cognitive ability re-
mains intact, long-term use of marijuana may cause subtle but
[potentially] lasting impairments in executive function. There is no
consensus, however, about whether this affects real-world function-
ing." 125
Although marijuana contains some beneficial cannabinoids,
marijuana smoke may also contain gases and other particles harmful
to the human body.12 6 Even though "[i]nhalation is the fastest way to
deliver THC to the bloodstream, . . . smoking marijuana exposes the
lungs to multiple chemicals and poses many of the same respiratory
health risks as smoking cigarettes."1 27 Like tobacco, smoking mari-
juana causes a "mild airway obstruction, chronic cough, bronchitis
and decreased [exercise tolerance and] pulmonary function."l 28  Al-
though marijuana and tobacco smoke contain many of the same car-
cinogenic components, a 1996 study examining the relationship be-
tween marijuana use and cancer incidence did not show any
121 See HARV. MENTAL HEALTH LETTER, supra note 102.
122 Andrysiak et al., supra note 73, at 1397.
123 Clark, supra note 99, at 42.
124 See Andrysiak et al., supra note 73, at 1397.
125 HARV. MENTAL HEALTH LETTER, supra note 102; see Joyce Cooper-Kahn & Laurie
Dietzel, What is Executive Functioning, LD ONLINE (2008), http://www.ldonline.org/article/
WhatIsExecutiveFunctioning%3F ("The executive functions are a set of processes that
all have to do with managing oneself and one's resources in order to achieve a goal. It is an
umbrella term for the neurologically-based skills involving mental control and self-
regulation.").
126 See HARV. MENTAL HEALTH LETTER, supra note 102.
127 Id. ("Limited research suggests that vaporizers may reduce the amount of harmful
chemicals delivered to the lungs during inhalation.").
128 Cohen, supra note 107, at 64-65. Although tobacco and marijuana produce similar
pulmonary ailments, a 1990 survey of members of the American Society of Oncology
showed that of more than one thousand respondents, "44% [of the oncologists] reported that
they had recommended marijuana to at least one patient." Clark, supra note 99, at 43. Also,
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significant association between marijuana use and cancer.129
Moreover, non-conclusive studies theorize that THC may af-
fect the immune system and could seriously injure AIDS patients us-
ing marijuana.' 30 Another study even suggested that "people who
used medical marijuana were more likely to develop pneumonia and
other respiratory problems, and experience vomiting, and diarr-
hea."l 31  However, since marijuana is illegally cultivated, it may "al-
so be contaminated by microorganisms and fungi, which can [even-
tually] cause possible infections by pathogenic organisms." 32 Unless
marijuana growth and production is regulated, the potential side ef-
fects will continue to remain unknown and may pose further health
risks to patients who use medical marijuana.
In addition to all of marijuana's potential side effects, a key
issue associated with prescribing medical marijuana is the difficulty
of determining the appropriate dosage.133 In order to effectively alle-
viate pain and the side effects associated with marijuana, the concen-
129 See Stephen Sidney et al., Mariuana Use and Cancer Incidence (California, United
States), 8 CANCER CAUSES & CONTROL 722, 727 (1997). The study examined 64,855 people
between 1979 and 1985, with ages ranging from fifteen to forty-nine years old. Id. at 722.
By examining nonsmokers of cigarettes who smoked marijuana and cigarette smokers who
smoked marijuana, the study showed associations between marijuana use and increased risk
of prostate cancer in males and cervical cancer in females who were marijuana users and
nonsmokers of cigarettes. Id. at 727. Although the incidence of lung cancer caused from
marijuana smoke remains largely unknown, a similar study found marijuana smoke, like to-
bacco smoke, contained ammonia at levels twenty times greater than in tobacco, as well as
concentrations of hydrogen cyanide. Cohen, supra note 107, at 65. However, in another
study comparing tobacco and marijuana smokers, both groups of " 'smokers reported cough-
ing and wheezing' . . . . [but] only tobacco smokers demonstrated signs of emphysema, a
chronic pulmonary disease." Id. at 66.
130 See Clark, supra note 99, at 44 (stating that these "nonconclusive studies have shown
that THC both suppresses macrophages and human T-lymphocytes and enhances macro-
phage secretion of interleukin-I (19)").
131 HARV. MENTAL HEALTH LETTER, supra note 102 (claiming that, nonetheless, these side
effects caused by medical marijuana were found to be relatively mild).
132 Clark, supra note 99, at 44.
1 See Cohen, supra note 107, at 53.
[Wihen used as medical therapy, marijuana is administered only in doses
sufficient to produce the desired clinical effect and only for as long as
medically necessary. The effects of any pharmaceutical agent, whether
beneficial or pathologic, depend on [several factors, including:] the route
of administration (e.g., oral, intravenous, intramuscular, or smoked), the
dose administered, the pharmacologically active fraction of the adminis-
tered dose that reaches the desired site of action, the rate at which the
drug is metabolically inactivated, and the frequency and duration of use.
Id
20
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tration of THC, the most active component, must be determined be-
cause it "varies according to the particular plant and [the method in
which] it is grown."1 34  For instance, "THC may intensify phantom
pain" in patients with physiological conditions.'3 5  Also, ingesting
food after taking "an oral dose of [marijuana] can increase the effects
of [THC] because fatty food may stimulate THC absorption"
throughout the patient's body.136  In order to secure effective treat-
ment for a patient, it is important to have knowledge of what treat-
ments work for particular symptoms and issues, and most important-
ly, for which patients. 137
D. Current Use and the Need for Further Research
Although THC is listed separately as a Schedule I controlled
substance and hallucinogen, the Controlled Substances Act supports
the production of synthetic THC.13 8 For example, Dronabinol (mar-
keted as Marinol) exists in pill form to treat nausea and vomiting in
cancer patients receiving chemotherapy "who have not responded to
[other] conventional . . . therapy."1 3 9 However, unlike smoked mari-
134 Clark, supra note 99, at 44. At low doses, THC can be sedating; whereas, at higher
doses, THC may induce episodes of anxiety. See HARV. MENTAL HEALTH LETTER, supra
note 102. "In the United States, THC concentrations in marijuana sold on the street used to
range from 1% to 4% of the total product; [yet] by 2003, the average THC concentration had
risen to 7%." Id. In addition to the quantity of THC absorbed, other factors that affect the
potency and subsequent euphoric effects of marijuana include the smoker's habitual use and
the amount of time that smoke is held in the lungs. See Cohen, supra note 107, at 62-63.
35 Andrysiak et al., supra note 73, at 1398.
136 id.
137 See HARV. MENTAL HEALTH LETTER, supra note 102. The use of marijuana and the
type of patient are closely linked. For instance, marijuana may contribute to psychiatric
problems, and although "[1]ittle controlled research has been done," patients with bipolar
disorder often use marijuana and suffer induced "manic episodes and increase[d] rapid cycl-
ing between manic and depressive moods." Id. Also, marijuana may increase psychotic
symptoms in patients diagnosed with schizophrenia, and studies suggest individuals who
smoked marijuana "in the[ir] early teen[s may have an] increase[d] risk of developing psy-
chosis." Id.
138 See ALEXANDER T. SHULGIN, CONTROLLED SUBSTANCES: A CHEMICAL AND LEGAL
GUIDE TO THE FEDERAL DRUG LAWS 86 (2d ed. 1992) (illustrating that the Controlled Sub-
stances Act designates THC as a Schedule II substance when the delta-9-(trans)-isomer of
THC is specifically "mixed with sesame oil and encased in a soft gelatin capsule," and the-
reby administered orally rather than inhaled).
139 Clark, supra note 99, at 43; see SHULGIN, supra, note 138, at 86. Under the Controlled
Substances Act, Dronabinol is listed under Schedule II meaning it "has a high potential for
abuse" and "may lead to severe psychological or physical dependence," but also "has a cur-
21
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juana, Marinol produces inconsistent effects because it is absorbed
slowly and the amount of medication that reaches the bloodstream
varies between patients.140  Furthermore, Marinol does not contain
cannabidiol ("CBD"), a chemical found in the plant extract of mari-
juana, resulting in "intense and unpleasant psychoactive reactions."'41
The NIH has identified CBD as a potential drug to "protect[] against
brain damage caused by [a] stroke," and may even help treat arthri-
tis.142
According to Mill, the freedom of choice of behavior should
be restricted to adults of sound mind and should not interfere with the
rights of others, but the federal government is restricting a patient's
individuality and pursuit of happiness before medical marijuana's
true harms are known.143  Until further controlled government re-
search can be performed on medical marijuana, the potential thera-
peutic purposes and risks will continue to remain unknown. Patients
rently accepted medical use in treatment in the United States or a currently accepted medical
use . . . with severe restrictions." 21 U.S.C.A. § 812(b)(2)(A)-(C).
140 HARV. MENTAL HEALTH LETTER, supra note 102. Since "[m]ost of the [THC in Mari-
nol] is metabolized during digestion, . . . only 10% to 20% of the original dose reaches the
bloodstream." Id Currently, the United States is investigating Sativex, a combination of
THC and Cannabidiol, used in Canada that is "referred to as 'liquid cannabis' because it is
sprayed under the tongue or elsewhere in the mouth, using a small handheld device." Id.
However, since Sativex must "be absorbed through tissues lining the mouth before it can
reach the bloodstream," it takes some time before any effects may be noticed. Id. "When
Marijuana is smoked, THC in the form of an aerosol ... is absorbed within seconds and de-
livered to the brain rapidly and [more] efficiently" than orally ingested THC. Marmor, supra
note 76, at 541 ("Maximum blood concentrations are reached about the time smoking is fi-
nished and then rapidly dissipate. Psychopharmacologic effects peak at [thirty] to [sixty]
minutes."). Conversely, oral ingestion of THC results in "subjective effects [that] last for
[five] to [twelve] hours without a clear peak" in psychopharmacologic effects. Id
141 BoIRE & FEENEY, supra note 67, at 83. CBD helps curb the intense intoxicating effect
of THC and "has properties that include: anti-convulsive, anti-anxiety, anti-psychotic, anti-
emetic, anti-inflammatory, anti-oxidant and sedative properties." Id.
142 Conboy, supra note 104, at 613. Unlike THC, "[1]ess is known about cannabidiol, al-
though the research suggests that it interacts with THC to produce sedation." HARV.
MENTAL HEALTH LETTER, supra note 102. Also, cannabidiol "may independently have anti-
inflammatory, neuroprotective or antipsychotic effects, although the research [remains] too
preliminary to be applied clinically." Id. Although the research has yet to be tested on hu-
man subjects, NIH's study has indicated that smoking marijuana instead of ingesting it "will
[probably] not provide an effective dose of the compound." Conboy, supra note 104 at 613.
Removing the euphoric effects caused by smoking marijuana, CBD works as a strong "anti-
oxidant that has successfully protected rat brain cells from a toxic chemical produced during
a stroke." Id.
143 See BERG ET AL., supra note 20, at 23-24. This seems to mean that a patient's right to
make medical decisions should be promoted in some circumstances, but should not grant the
patient freedom to use any and all medical care they desire. Id. at 24.
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suffering from AIDS, cancer, chronic pain, glaucoma, and arthritis
would greatly benefit from federally regulated medical marijuana to
alleviate the pain associated with their chronic and terminal ill-
nesses.14 4 Thus, the federal government is restricting the freedom of
behavior and choice of sound adults who have rationally chosen med-
ical marijuana for therapeutic use.
Furthermore, because there is no control of the purity or
strength of marijuana, the benefits and harms remain skewed.145 Un-
regulated marijuana may be contaminated with substances that may
harm AIDS and cancer patients, and make them more susceptible to
disease due to weakened immune systems.14 6 As long as marijuana
remains a Schedule I drug under the Controlled Substances Act, pa-
tients relying on medical marijuana will be subject to criminal liabili-
ty and inevitably forced to seek out illegally grown and unregulated
sources of marijuana. 147 Therefore, until the federal government be-
gins to engage in meaningful research and regulation of medical ma-
rijuana, the majority of patients will be denied an effective treatment,
as well as their right to make an informed choice.
III. LEGAL STATUS OF MEDICAL MARIJUANA
A. Early Legislation: Historical Use of Marijuana
In the United States, Europeans "introduced marijuana (hemp)
into Massachusetts [in 1629] to be cultivated and used as a fiber for
rope and other products." 48 Through the establishment of the early
colonies, "[h]emp eventually became a major crop in America." 49
By 1762, Virginia required its citizens to grow marijuana and even
imposed penalties on those who refused to grow it. 0 Additionally,
marijuana was included in the United States Pharmacopoeia in 1850
as a treatment for numerous ailments, "including: neuralgia, tetanus,
typhus, cholera, rabies, dysentery, alcoholism, opiate addiction, anth-
w See Medical Maryuana for Pain and Depression, DISABLEDWORLD.COM
http://www.disabledworld.com/medical/pharmaceutical/marijuanal (last visited Nov. 4,
2010).
145 See Marmor, supra note 76, at 542.
146 See id.
147 See id.; see also 21 U.S.C.A. § 812(c); 21 U.S.C.A. § 841(b)(1)(C) (West 2010).
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rax, leprosy, incontinence, gout, convulsive disorders, tonsillitis, in-
sanity, excessive menstrual bleeding and uterine bleeding.""' Since
marijuana was considered a valuable medication, marijuana was not
subject to federal or state regulation until California and Utah first
prohibited its possession or sale in 1915.152 In that same year, "The
U.S. Treasury Department [initially] prohibited the importation of
marijuana for nonmedical purposes."' 53
As the federal government abandoned its moral crusade
against alcohol in the 1930s, the U.S. Treasury Department estab-
lished the Federal Narcotics Bureau which, under the supervision of
Henry Anslinger, began the fight to prohibit marijuana use. 54 Al-
though opposed by the American Medical Association, the federal
government attempted to " 'tax [marijuana] out of existence' " by
passing the Marijuana Tax Act of 1937, which in effect was really a
de facto prohibition on the use of marijuana, including medicinal
uses.'55  Furthermore, Anslinger successfully removed marijuana
from the United States Pharmacopoeia in 1941.15' By "1951, the
Boggs Act [implemented] mandatory prison sentences and ... mone-
tary fines" for possession of marijuana, which were only reinforced
151 BoiRE & FEENEY, supra note 67, at 16.
152 See MOLLER, supra note 148, at 11. Following California and Utah, "and before alco-
hol was again legalized in 1933, thirty-two additional states" regulated the use of marijuana
based on the establishment of two fears. Id. "The first was a racially motivated hostility to-
ward the 500,000 Mexicans who immigrated to America between 1915 and 1930, many of
whom smoked marijuana." Id. Secondly, there was "a fear that the underworld-
prostitutes, pimps, and gamblers-who were 'notorious' drug users-would entice good citi-
zens . .. to become 'dope fiends.' " Id. (emphasis added).
1 MOLLER, supra note 148, at 11.
154 Id. (noting that in 1932, the Bureau recommended that all states should adopt the Uni-
form Narcotic Drug Act). Interestingly, the Act did not prohibit marijuana, but only "classi-
fied [it] as an optional drug that could be . . . added to the list of 'narcotic drugs' by any
state" that chose to do so. Id However, "by 1937, forty-six of the forty-eight [existing]
states, plus the District of Columbia, had [enacted] laws prohibiting marijuana." Id.
1ss Conboy, supra note 104, at 601-02 (alteration in original). See also BOIRE & FEENEY,
supra note 67, at 18-19 ("The Marihuana Tax Act ... required all manufacturers, importers,
dealers and medical practitioners dealing with marijuana to register with the federal govern-
ment and to pay a special occupational tax."). In fact, Dr. William C. Woodward spoke on
behalf of the AMA stating: "The obvious purpose and effect of this bill is to impose so many
restrictions on the medicinal use as to prevent such use altogether ... it may serve to deprive
the public of the benefits of a drug on further research may prove to be of substantial value."
Id. at 19.
1s6 BoiRE & FEENEY, supra note 67, at 19 (adding that Anslinger was also one of the chief
architects of the Marihuana Tax Act of 1937).
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by the Narcotic Control Act of 1956.'15
B. Federal Legal Status
1. The Final Straw: Controlled Substances Act
By 1970, it was only too clear that marijuana would no longer
be granted the freedom it was once afforded in American society.
With the implementation of the Controlled Substances Act, Congress
established five schedules into which a drug may be placed.'" 8 Mari-
juana is classified as a Schedule I controlled substance, the most re-
strictive schedule out of five.' 5 9 By its Schedule I classification, the
Attorney General has determined that marijuana "has no currently
accepted medical use in treatment in the United States," "has a high
potential for abuse," and "[t]here is a lack of accepted safety for use
... under medical supervision."160  Consequently, the Controlled
Substances Act makes it unlawful for any person to "knowingly or
intentionally . . . manufacture, distribute, or dispense, or possess with
intent to manufacture, distribute, or dispense, a controlled sub-
stance."' 6 '
'5 Conboy, supra note 104, at 602. See BoIRE & FEENEY, supra note 67, at 20 ("Follow-
ing World War II, a perceived increase in the use of narcotics along with a growing culture
of paranoia, fueled by McCarthyism, led to a new drug hysteria and. . . . [t]he passage of the
Boggs Act."). Although the Act "focused predominantly on the use of narcotics, the debate
leading to its passage cemented the notion that use of marijuana leads to the use of harder
drugs." Id. Consequently, marijuana was listed along side narcotics, which created the"
'gateway [drug] theory' " underlying marijuana prohibition even today. Id.
158 See 21 U.S.C.A. § 812.
15 See id. § 812(c); see also SHULGIN, supra note 138, at 128-29. Marijuana is listed as a
Schedule I substance, particularly as a Hallucinogen; this includes marijuana in the forms of
marijuana (granulated, powdered, etc.), marijuana plant, marijuana seeds, marijuana resin
(hashish), marijuana oil (hash oil, liquid oil), and cannabis in three forms: extract, fluid ex-
tract, and tincture. Id. at 128. Also, THC is listed separately as a Schedule I and Hallucino-
gen. Id. However, additional compounds present in the plant extract are known and not in-
cluded as a scheduled drugs including, Cannabidiol, Cannabinol, Cannabichromene,
Cannabinol Acetate, Cannabicycol, and Cannabigerol. Id. at 129.
'0 21 U.S.C.A. § 812(b)(1)(A)-(C).
16' 21 U.S.C.A. § 841(a)(1). See also BOIRE & FEENEY, supra note 67, at 21. During the
formation and passing of the Controlled Substances Act in 1970, many congressmen, in-
cluding Senator Ted Kennedy, opposed marijuana's classification as a Schedule I substance.
Id. Consequently, marijuana was temporarily placed in Schedule I pending a federal investi-
gation by a presidential commission called the Shafer Commission, which was composed of
thirteen members, largely congressmen opposed to rescheduling marijuana, appointed by
President Nixon and Congress. Id. In the report, the Commission rejected the legalization of
marijuana, but "urged the withdrawal of criminal sanctions for personal use of marijuana."
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Since marijuana remains a Schedule I drug, possession of ma-
rijuana is illegal unless the federal government has made it available
for an approved research project under the Controlled Substances
Act. 162 The Attorney General may register applicants to manufacture
and distribute Schedule I or II substances if he determines such regis-
tration is consistent with the public interest, and in doing so, the fol-
lowing factors considered include, but are not limited to:
(1) maintenance of effective controls against diversion
of particular controlled substances . .. in schedule I or
II compounded therefrom into other than legitimate
medical, scientific, research, or industrial channels
.. .; (2) compliance with applicable State and local
law; [and] (3) promotion of technical advances in the
art of manufacturing these substances and the devel-
opment of new substances.163
However, since the federal government is hesitant to distri-
bute marijuana for research, it is increasingly difficult to obtain re-
search approval and access to marijuana.' 1 The National Institute on
Drug Abuse ("NIDA") possesses "[t]he only legal and controlled
source of marijuana" on a farm in Mississippi.165 Although the fed-
eral government has an approved source of legalized marijuana, re-
searchers can only obtain this federal marijuana after the NIH has
completed a peer review of the research project and the NIDA has
granted approval.166
2. Wishful Thinking:
Controlled Substances Act Rescheduling
Although a drug has been placed into a particular schedule,
Id. at 22. Although the Commission recommended marijuana as a treatment for " 'glauco-
ma, migraine, alcoholism and terminal cancer," President Nixon ignored the Commission's
findings. Id.
162 See 21 U.S.C.A. § 823(f) (West 2010).
161 Id. § 823(a)(l)-(3).
1'" See id. § 823(f) (specifying that the Attorney General has the authority to register or
deny applicants for research only on controlled substances in schedules II, III, IV, or V and
therefore, research on marijuana as a schedule I controlled substance is effectively denied).
165 Marmor, supra note 76, at 542.
166 See id. (illustrating that even the NIH recognized "that the current regulatory system
should be modified to remove barriers to clinical research with controlled substances").
[Vol. 27364
26
Touro Law Review, Vol. 27 [2011], No. 2, Art. 7
https://digitalcommons.tourolaw.edu/lawreview/vol27/iss2/7
MEDICAL MARIJUANA
the Attorney General may "remove any drug or other substance from
the schedules if he finds that the drug or other substance does not
meet the requirements for inclusion in any schedule." 67  However,
before a drug can be removed, the Attorney General must examine
the Secretary of Health and Human Services' medical and scientific
evaluation of the substance and consider the following criteria:
(1) Its actual or relative potential for abuse. (2) Scien-
tific evidence of its pharmacological effect, if known.
(3) The state of current scientific knowledge regarding
the drug or other substance. (4) Its history and current
pattern of abuse. (5) The scope, duration, and signi-
ficance of abuse. (6) What, if any, risk there is to the
public health. (7) Its psychic or physiological depen-
dence liability. (8) Whether the substance is an im-
mediate precursor of a substance already controlled
under this subchapter. 168
Following the enactment of the Controlled Substances Act,
the National Organization for the Reform of Marijuana Laws
("NORML") petitioned the Drug Enforcement Agency ("DEA") to
reschedule marijuana to Schedule V in 1972.169 If marijuana was
removed to Schedule V, it would be considered both a socially and
medically accepted drug with "a low potential for abuse," "a current-
ly accepted medical use in treatment in the United States," and
"abuse of the drug . .. may lead to a limited physical . .. or psycho-
logical dependence."o7 0 However, the DEA Administrator denied the
motion to transfer marijuana from Schedule I to V.17 1
Although rescheduling marijuana into Schedule V would have
6 21 U.S.C.A. § 811(a)(2) (West 2010). Although the Attorney General has the authori-
ty to conduct the investigation into the drug's scheduling, the proceedings "may be initiated
by the Attorney General ... on his own motion,.. . at the request of the Secretary [of Health
and Human Services], or ... on the petition of any interested party." Id
161 Id. § 811 (b)-(c). The Attorney General essentially shares his decision-making authori-
ty with the Secretary of Health and Human Services. See id. § 811(b). The Attorney Gener-
al is bound by the Secretary's medical and scientific evaluation, so "if the Secretary recom-
mends that a drug or other substance not be controlled, the Attorney General shall not
control the drug or other substance." Id.
169 See Nat'l Org. for the Reform of Marijuana Laws v. DEA (NORML), 559 F.2d 735,
741 (D.C. Cir. 1977).
170 See 21 U.S.C.A. § 812(b)(5)(A)-(C).
17 NORMIL, 559 F.2d at 753.
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been a huge stretch, NORML argued that marijuana should at least be
rescheduled into Schedule II.172 Accordingly, like other Schedule II
substances, including opium and methadone, marijuana would be
considered to have "a high potential for abuse" and "may lead to se-
vere psychological or physical dependence," but more importantly,
marijuana would have an "accepted medical use in treatment in the
United States or a currently accepted medical use with severe restric-
tions."1 73
In National Organization for the Reform of Mari uana Laws
(NORML) v. DEA,1 74 the court held that the Attorney General was
bound by the Secretary of Health, Education, and Welfare's medical
and scientific evaluations when rescheduling a controlled sub-
stance.17 5  By seeking rescheduling of marijuana from Schedule I,
NORML argued that the Attorney General could override the Secre-
tary of Health, Education, and Welfare's medical and scientific eval-
uations "to the extent those recommendations conflict with" the Unit-
ed States' commitments under the United Nation's Single Convention
on Narcotics Drugs (1967).176 The court reasoned that the Attorney
General could make legal judgments as to controls on drugs accord-
ing to international commitments and then establish a minimum
schedule or control for the drug.177 After reviewing the Secretary's
medical and scientific evaluations, the Attorney General would de-
termine if more restrictive controls needed to be imposed. 7 1
More importantly, the court directed the acting Administrator
to refer NORML's petition to the Secretary of Health, Education, and
Welfare for medical and scientific findings and recommendations for
rescheduling marijuana.179  Although Francis L. Young, the Chief
Administrative Judge for the DEA, determined marijuana belonged in
See id at 751.
173 21 U.S.C.A. § 812(b)(2)(A)-(C).
174 559 F.2d 735.
171 See NORML, 559 F.2d at 746-47.
176 Id at 738-40. The Controlled Substances Act and the Single Convention provided dif-
ferent definitions of marijuana as "cannabis" and "cannabis resin," listing marijuana as a
Schedule I and Schedules I and IV respectively. Id. at 739-40. Under the Single Conven-
tion, cannabis has a relatively high abuse liability under Schedule I, and as a Schedule IV
substance, cannabis resin has an abuse liability not offset by substantial therapeutic advan-
tages. Id.
1n See id. at 746.
17 See NORML, 559 F.2d at 746-47.
179 Id. at 757 (concluding that the acting DEA Administrator believed cannabis and can-
nabis resin should be rescheduled to Schedule II consistent with the Single Convention).
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Schedule II, Congress and the DEA have firmly stood by their posi-
tion that marijuana has no currently accepted medical use in treat-
ment.'8 0 Accordingly, state laws, such as California's Compassionate
Use Act of 1996, are in direct conflict with federal law.'
C. State Legal Status
1. The California Standard
Under the Compassionate Use Act of 1996, California set the
standard for patient autonomy by approving the medical use of mari-
juana.182  Through voter approval, California sought "to ensure that
seriously ill Californians have the right to obtain and use marijuana
for medical purposes where that medical use is deemed appropriate
and has been recommended by a physician who has determined that
the person's health would benefit from the use of marijuana." 83
While exempting patients and physicians from criminal prosecution
or sanction, California sought a collaborative effort between the fed-
eral and state governments "to implement a plan to provide for the
safe and affordable distribution of marijuana to all patients in medical
need of marijuana." 8 4
Although California established an identification card pro-
gram, patients may register on a voluntary basis, but once validly reg-
istered, a patient will not face criminal prosecution "for possession,
transportation, delivery, or cultivation of medical marijuana."' 8 5  In
order to receive an identification card, a patient must provide written
documentation that his or her physician diagnosed him or her with a
"serious medical condition" and determined that the use of medical
1so See BoIRE & FEENEY, supra note 67, at 25-26. On September 6, 1988, Young stated
that "one must reasonably conclude that there is accepted safety for use of marijuana under
medical supervision. To conclude otherwise, on this record, would be unreasonable, arbi-
trary and capricious." Id However, "federal agencies are not bound by the recommenda-
tions of their own administrative law judges." Id. at 26. Ultimately, then DEA Administra-
tor John Lawn rejected Judge Young's recommendation on December 29, 1989. Id.
181 See CAL. HEALTH & SAFETY CODE § 11362.5(b)(1)(A) (West 2010).
182 id.
' Id § 11362.5(b)(1)(A). Under section 11362.5(b)(1)(A), marijuana may be used only
for serious medical conditions, including "the treatment of cancer, anorexia, AIDS, chronic
pain, spasticity, glaucoma, arthritis, migraine, or any other [chronic or persistent] illness for
which marijuana provides relief." Id
1" Id. § 11362.5(b)(1)(B)-(C).
185 CAL. HEALTH & SAFETY CODE § 11362.71(a)(1), (e) (West 2010).
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marijuana was an appropriate treatment.' 8 6  This ensures that a pa-
tient has a true medical necessity for medical marijuana and that
medical marijuana is not an arbitrary treatment. While California
limits the amount of marijuana that a patient may possess, a patient
may essentially carry a quantity according to a physician's recom-
mendations based on the patient's needs. 7
2. States Falling in Line
Following California's example to respect a patient's auton-
omy in choosing to utilize medical marijuana as treatment, several
states, including Alaska, Vermont, Hawaii, Maine, Michigan, Mon-
tana, Oregon, New Mexico, Rhode Island, Nevada, New Jersey, and
Washington have legalized medical marijuana.' 8 8  However, unlike
California, these states require that patients who have been prescribed
medical marijuana by their physician must enter into a patient regi-
stry.' 89 Before a patient can receive a registration identification card,
a physician must diagnose the patient with a "debilitating medical
condition" in the context of a bona fide patient-physician relationship
and determine that such patient will benefit from the use of medical
marijuana.'90 Also, the doctor must discuss alternative treatments
186 CAL. HEALTH & SAFETY CODE § 11362.715(a)(2) (West 2010). Additionally, under
section 11362.76(a)(2)(A), a patient must annually submit written documentation of his or
her debilitating medical condition to ensure the patient still has a necessity for medical mari-
juana in the pursuit of effective treatment. CAL. HEALTH & SAFETY CODE §
11362.76(a)(2)(A) (West 2010).
187 CAL. HEALTH & SAFETY CODE § 1 1362.77(a)-(b) (West 2010) (stating that "[a] quali-
fied patient or primary caregiver may possess no more than eight ounces of dried marijuana .
... [and] no more than six mature or [twelve] immature marijuana plants per qualified pa-
tient"). However, this provision is considered invalid because it is preempted by federal law
under the Controlled Substances Act. Id.
188 See ALASKA STAT. § 17.37.010; HAw. REV. STAT. § 329-123(b); ME. REV. STAT. tit.
22, § 2425; MICH. Comp. LAWS § 333.26424; MONT. CODE ANN. § 50-46-103; NEV. REV.
STAT. § 453A.050; N.J. STAT. ANN. § 24:61-4; N.M. STAT. ANN. § 26-2B-4(D); ORE. REV.
STAT. § 475.309(2)(a); R.I. GEN. LAWS § 21-28.6-4; VT. STAT. ANN. tit. 18, § 4473; WASH.
REV. CODE § 69.5 1A.005.
189 Id Currently, Maine, Rhode Island, Washington, and Hawaii's medical marijuana sta-
tues are only proposed legislation and wait further approval. New Jersey passed its Compas-
sionate Use Medical Marijuana Act in June 2009, which became effective on July 1, 2010.
N.J. STAT. ANN. 24:61-1.
190 See ALASKA STAT. § 17.37.010(c)(1)(A)-(C) (requiring patients to obtain registry iden-
tification card); id. § 17.37.070(2). Under both provisions, a bonafide physician-patient re-
lationship means that the physician obtained a patient history, performed an in-person physi-
cal examination of the patient, and documented written findings, diagnoses,
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with the patient before prescribing marijuana.' 91 By promoting the
physician-patient relationship, these states have effectively respected
the patient's autonomy as a rational being capable of making in-
formed medical decisions and promoted the state interest in preserv-
ing life.
Additionally, these patient registry states will neither subject
the patient to arrest, prosecution, or penalty for being listed in the re-
gistry, nor subject the physician to penalty, prosecution, arrest, or
disciplinary action for prescribing marijuana.' 92 However, several
restrictions have been placed on the privileged use of marijuana. Fol-
lowing Mill's harm principle, these states ensure that a patient or ca-
regiver will not use marijuana in a way that directly harms or endan-
gers the health or well being of any person, such as driving under the
influence of marijuana or using marijuana in plain view of the gener-
al public unless it is in a closed container. 193
Unlike other states that have passed medical marijuana legis-
lation through voter initiatives, Colorado and Nevada amended their
state constitutions to allow the use of medical marijuana; under the
Colorado and Nevada Amendments, marijuana may be prescribed to
patients with debilitating medical conditions, such as cancer, AIDS,
and symptoms associated with MS.194 Additionally, Colorado's state
recommendations, and prescriptions in written patient medical records maintained by the
physician. Id. See also HAW. REV. STAT. § 329-122(a) (West 2010); ME. REV. STAT. ANN.
tit. 22, § 2427(1)(A) (West 2010); MICH. COMP. LAWS ANN. § 333.26428(a)(1) (West 2010);
N.M. STAT. ANN. § 26-2B-3(B) (West 2010); ORE. REV. STAT. § 475.309(2)(a); R.I. GEN.
LAWS § 21-28.6-3(3) (2010); VT. STAT. ANN. tit. 18, § 4473.
'19 See ALASKA STAT. § 17.37.010(c)(1). By invoking the doctrine of informed consent,
this provision ensures that the physician has discussed not only the preferred medical treat-
ment, but also other alternatives and their associated risks and benefits. Id
192 See ALASKA STAT. § 17.37.030(b)-(c) (2010) (listing the privileged uses of medical
marijuana for patients and physicians). However, under subsection (d), both the patient and
physician will be subject to prosecution, arrest, or penalty for the possession, use or sale of
marijuana for nonmedical use. Id. See also MONT. CODE ANN. § 50-46-201 (2010); N.M.
STAT. ANN. § 26-2B-4(D)-(E); R.I. GEN. LAWS § 21-28.6-8 (2010); VT. STAT. ANN. tit. 18, §
4474b(a)-(b) (2010).
19 See ALASKA STAT. § 17.37.040(a) (2010) (listing restrictions on the use of medical ma-
rijuana). Under subsection (a)(4), a patient can only carry "one ounce [or less] of marijuana
in usable form[, or] six marijuana plants, with no more than three mature and flowering
plants producing usable marijuana at any one time." Id. § 17.37.040(a)(4). See also HAW.
REV. STAT. § 329-122; MICH. COMP. LAWS ANN. § 333.26424; N.J. STAT. ANN. § 24:61-1
(West 2010); R.I. GEN. LAWS § 21-28.6-7 (2010); WASH. REV. CODE § 69.51A.060 (2010).
'94 See COLO. CONST. art. 18, § 14(l)(a)(I)-(1I); NEV. CONST. art. 4, § 38(l)(a); see also
NEV. REV. STAT. § 453A.050. Additionally, such debilitating medical conditions include, but
are not limited to, glaucoma, HIV, relieving symptoms of cachexia, severe pain, severe nau-
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health agency may further determine and approve the use of medical
marijuana to treat other medical conditions pursuant to either its own
authority or petition by a patient or physician.'9 5 In order to lawfully
possess and use medical marijuana, a patient must be placed on the
state's confidential registry after a physician diagnoses the patient
"with a debilitating medical condition and . . . conclu[des] that the
patient might benefit from the medical use of marijuana."' 96  Al-
though the patient may use an amount of marijuana medically neces-
sary to treat the debilitating medical condition, the patient must not
use marijuana "in a way that endangers the health or well-being of
any person."' 9 7
3. States Moving Towards Legalization
Lastly, several states either have not completely legalized the
use of medical marijuana or are currently considering legislation. 9 8
Although marijuana is listed as a Schedule I substance, Arizona al-
lows physicians to use marijuana "to treat a disease, or to relieve the
pain and suffering of a seriously ill patient or terminally ill pa-
tient."' 99 However, the Arizona statute strictly regulates and limits
the physician's ability to prescribe medical marijuana as a potential
treatment.200 The physician can prescribe medical marijuana only af-
ter he or she has documented scientific research supporting the use of
marijuana for treatment, obtained a second opinion from another phy-
sician supporting marijuana as the appropriate treatment, and re-
sea, and seizures, including those that are characteristic of epilepsy. NEV. REv. STAT.
§ 453A.050.
19s See COLO. CONST. art. 18, § 14(1)(a)(III); see also COLO. REV. STAT. § 25-1.5-106
(2010) (describing the powers and duties of the Colorado Department of Public Health).
196 COLO. CONST. art. 18, § 14(3)(b)(I). See also NEV. CONST. art. 4, § 38(1)(a), (d); NEV.
REV. STAT. § 453A.210 (2010). However, under section 453A.310(1)-(2) of the Nevada Re-
vised Statutes, a person diagnosed with a debilitating medical condition by a physician who
believes marijuana may be an effective treatment for that condition and does not possess a
registry identification card may still assert an affirmative defense against any charge of pos-
session, delivery, or production of marijuana. NEV. REV. STAT. § 453A.310(1)-(2) (2010).
197 COLO. CONST. art. 18, § 14(5)(a)(I). The State has determined that a patient may not
possess "more than two ounces of a usable form of marijuana[,] and [n]o more than six mari-
juana plants .. . [as] a usable form." Id. § 14(4)(a).
198 See, e.g., ARIZ. REV. STAT. ANN. § 13-3412.01 (2010); MD. CODE ANN., CRIM. LAW §
5-601.
19 ARIZ. REV. STAT. ANN. § 13-3412.01.
200 See id. (listing various requirements doctors must satisfy as condition precedents be-
fore prescribing marijuana to patients).
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ceived the patient's written consent. 201 Lastly, while Maryland is the
most recent state to approve marijuana legislation, "New York, Illi-
nois, Delaware, South Dakota, ... and Kansas are" moving towards
proposed legislation.202
D. Federal and State Law:
The Struggle for the Terminally Ill
Although most courts accept a right of personal autonomy,
particularly as a crucial aspect of medical decision-making, an indi-
vidual will inevitably be forced to "yield . . . to the greater good of
society."203 In United States v. Oakland Cannabis Buyers' Coopera-
tive,204 the Supreme Court held there is no defense of medical neces-
sity to manufacturing and distributing marijuana.2 05 In Oakland
Cannabis Buyers' Cooperative, the United States sought "to enjoin
the Cooperative from distributing and manufacturing marijuana."206
As a not-for-profit organization that distributed marijuana to patients
whose physicians prescribed marijuana therapy, the Cooperative op-
erated under the supervision of "[a] physician serv[ing] as medical
director, and registered nurses [as] staff."207  Under California's
Compassionate Use Act of 1996, these patients legally sought medi-
cal marijuana to alleviate severe pain and other debilitating symp-
toms. 208
However, by rejecting the Cooperative's stance that medical
necessity should be read into the Controlled Substances Act, the
Court reasoned that a legal necessity "defense cannot succeed when
201 id.
202 Grim, supra note 3. See also Maryland Darrell Putman Compassionate Use Act, MD.
CODE ANN., CRIM. LAW § 5-601(c)(3)(ii) (highlighting the court's consideration of medical
necessity as a mitigating factor in possession of marijuana prosecutions).
203 See Elizabeth Weeks Leonard, The Public's Right to Health: When Patient Rights
Threaten the Commons, 86 WASH. U. L. REV. 1335, 1336 (2009).
204 532 U.S. 483 (2001).
205 Id. at 494.
206 Id. at 486-87.
207 Id. at 486.
208 CAL. HEALTH & SAFETY CODE § 11362.5(b)(1)(A). A 1997 survey showed that out of
the 900 members of the Oakland Cannabis Buyers' Cooperative, "62% ha[d] AIDS . . . ,
10% used marijuana for pain or arthritis, 8% for mood disorders, 6% for neurologic symp-
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the legislature . . . has made a 'determination of values.' ,209 Al-
though the Cooperative argued that Congress, and not the Attorney
General, classified marijuana as a Schedule I drug, the Court relied
on the simple "determination that marijuana had no medical benefits
[that would allow] an exception" for medical use.2 10 By strictly en-
forcing Mill's harm principle, the Court has apparently interfered
with the Cooperative's individual liberty to prevent direct harm to
others.21' While the federal government nobly intends to protect so-
ciety from widespread drug use, the government has ultimately ig-
nored reason in order to reach this decision.
According to Kant, an action is morally good only if it is
guided by reason, but the government has hastily taken misguided ac-
tions to protect the general public.212 Consequently, the federal gov-
ernment, through the regulation of medical marijuana, has denied
terminally ill patients' worth as rational beings. By restraining a pa-
tient's freedom to practice his or her autonomy, the government has
sought its own "happiness" to seemingly protect the rest of society
from harm at the cost of denying a patient's right to live, and ulti-
mately die, with dignity.2 13
Through the physician-patient relationship, both patient and
physician work together to promote autonomy by finding a treatment
method that will uphold the patient's right to avoid pain. This is an
inherent right belonging to every human being and it is even more
fundamental to a terminally ill patient.214 The federal government
has imposed restraints on a patient's individuality of choice by inter-
fering with a terminally ill patient's right to avoid pain. Simply put,
the argument for medical marijuana is that no one should be forced to
suffer severe physical pain, whether self-imposed or by the state or
209 Oakland Cannabis Buyers'Coop., 532 U.S. at 491.
210 Id. (noting that the issue of whether federal courts have authority to recognize a neces-
siy defense not provided by statute remains open).
2 See Heydt, supra note 24.
212 See McCormick, supra note 26 ("[T]he morality of our actions does not depend upon
their outcome.... The morality of an action, therefore, must be assessed in terms of the mo-
tivation behind it.").
213 See Heydt, supra note 24 ("Yet the world's good is made up of the good of the indi-
viduals that constitute it and unless we are in the position of, say, a legislator, we act proper-
ly by looking to private rather than to public good.").
214 See Last Resorts, supra note 11, at 1990, 1994 ("[P]rohibitions on the last-resort use of
medical marijuana make it impossible to exercise an array of fundamental rights.. . . The
pursuit of physician-assisted suicide and the choice to use medically necessary marijuana to
avoid severe pain at the end of life implicate the same values.").
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federal government, where a safe and effective remedy is availa-
ble.215 By denying last resort methods of avoiding pain, a patient
cannot maintain his or her self-dignity and self-definition.2 16
For terminally ill patients, the ability to live life comfortably
and enjoy their final days as they see fit is the ultimate expression of
autonomy. Nothing is more vital to a terminally ill patient than self-
definition, which "include[s] life, health, . . . minimiz[ing] unneces-
sary suffering, dignity, [and] autonomy." 217  Yet in 2005, the Su-
preme Court dealt the final blow to medical marijuana laws conflict-
ing with federal law. In Gonzales v. Raich,218 the Court held that the
Controlled Substances Act provisions criminalizing the manufacture,
distribution, and possession of marijuana as applied to intrastate
growers and users for medical purposes did not violate Congress's
Commerce Clause power. 2 19 Angel McClary Raich continued to suf-
fer from serious medical conditions after other conventional treat-
ments proved to be ineffective or resulted in intolerable side ef-
fects. 220 After Raich's physician concluded marijuana was the only
drug available to provide effective treatment, she used medical mari-
juana and experienced immediate, but not total, relief from her nau-
221sea and constant pain.22 Since marijuana is a Schedule I substance,
Raich was forced to use marijuana that local growers personally cul-
tivated.222 Consequently, the DEA raided the home of Diane Mon-
son, another respondent in this case, and seized and destroyed Mon-
son's homegrown marijuana plants.223
Although Raich's physician had approved her use of marijua-
na, the Court refused to accept this argument because "[t]he [Con-
trolled Substances Act] requires manufacturers, physicians, pharma-
cies, and other handlers of controlled substances to comply with
215 See id. at 1994 ("[T]he Court's substantive due process jurisprudence ... support[s] a
right against being forced by the state to suffer otherwise-avoidable physical pain. . . .
[Slubstantive due process cases suggest that the right also includes freedom from state-
im osed restraints on last-resort methods of avoiding pain.").
See id at 1995 ("The fact that severe physical suffering is, for some, an obstacle to
dignity and to free self-definition places this right squarely within the autonomy approach to
substantive due process.").
217 Id. at 1988.
. 545 U.S. 1 (2005).
219 See id. at 22.
220 See id at 7-8.
221 See id at 7.
222 id
223 Gonzales, 545 U.S. at 7.
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statutory and regulatory provisions."224 Even after prescribing con-
ventional medicines, Raich's physician determined that medical mari-
juana was the only drug available to effectively treat her symp-
toms. 225  In fact, Raich's physician stated that denying the use of
marijuana treatment would certainly "cause Raich excruciating pain
and could very well prove fatal." 226 Yet the Court failed to realize
that the right to life is one of preservation and one that government
has no legitimate interest in impeding.227
Furthermore, although Raich was a terminally ill patient and
used marijuana in compliance with California's Compassionate Use
Act, the Court upheld Congress's power to regulate activities that
substantially affect interstate commerce.228 Applying Wickard v. Fil-
burn,229 the Court firmly upheld Congress's Commerce Clause power
"to regulate purely local activities that are part of an economic 'class
of activities' that have a substantial effect on interstate commerce." 230
The Court reasoned that the homegrown consumption of marijuana
for medical purposes by Raich had a substantial effect on interstate
commerce "in both [the] lawful and unlawful drug markets."23'
Since marijuana is classified as a Schedule I drug, Congress has the
discretionary and explicit power to regulate it, even if used for medi-
cal purposes.232 However, by focusing on the economic impact of
prescribing and growing medical marijuana, rather than the intimate
personal choice of a suffering patient, the Court ultimately ignored a
224 Id. at 27.
221 See id. at 7.
226 id.
227 See Last Resorts, supra note 11, at 1991-92 ("For these patients, denial of lifesaving
treatment surely implicates the fundamental interest in living. In this analysis, it is of little
importance that the risk of death is caused not by direct state action, but rather by a preexist-
ing health condition for which the state seeks to withhold treatment.").
8 See Gonzales, 545 U.S. at 22.
229 317 U.S. 111 (1942).
230 Gonzales, 545 U.S. at 17 (citing Wickard, 317 U.S. at 128-29).
231 Id. at 19. The Supreme Court reasoned that it was "appropriate to include marijuana
grown for home consumption in the [Controlled Substances Act because of] the likelihood
that the high demand in the interstate market will [subsequently] draw . . . marijuana into
[the black] market." Id. The Court went on to state that "the diversion of homegrown mari-
juana tends to frustrate the federal interest in eliminating commercial transactions in the in-
terstate market in their entirety." Id.
232 See id. at 14. Yet eight years earlier, by holding there was no fundamental right to
physician-assisted suicide, the Supreme Court reasoned that "[p]ublic concern and democrat-
ic action are . . . focused on . . . protect[ing a terminally ill patient's] dignity and indepen-
dence at the end of life." Washington v. Glucksberg, 521 U.S. 702, 716 (1997).
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terminally ill patient's autonomy to choose medical treatment that
could have preserved his or her life and dignity before death.233
When medical marijuana solely provides relief for a patient,
the government should not impose barriers on the only effective me-
thod of avoiding pain.234 These terminally ill patients consulted their
physicians and after trying other conventional treatments, rationally
concluded that medical marijuana was the only effective alternative
treatment available to them. By following Kant's categorical impera-
tive and Mill's principle of utility, these patients made informed deci-
sions guided not only by reason, but also by the pursuit of individual
happiness.235 It is true that "[t]he autonomous actions of [a patient]
must not infringe upon the rights of another." 236 While autonomy is
not an absolute principle, these terminally ill patients were not threat-
ening the health of others because they used medical marijuana in
their own privacy to treat severely debilitating medical conditions.
Although the Supreme Court and federal government follow Mill's
harm principle, these patients should not be denied the right to die
with bodily integrity, control their final moments of life, and avoid
unnecessary physical suffering.237
IV. CONCLUSION
In the pursuit of autonomy, the patient and physician's prima-
ry focus is to protect the patient's independent process of self-
definition. Regardless of the identity that a terminally ill patient
233 See Last Resorts, supra note 11, at 1996-97 ("[Flor a last-resort patient, medical mari-
juana is, by hypothesis, the only way to stay alive, die with dignity, or avoid pain.").
234 See Glucksberg, 521 U.S. at 729. Focusing on a patient's right to life, the Supreme
Court further reasoned that both the federal and state governments have a strong interest in
preserving the lives of patients who not only want to enjoy the remainder of their lives, but
also want to be part of society. Id.
235 See McCormick, supra note 26 ("The categorical imperative is Kant's famous state-
ment of this duty: 'Act only according to that maxim by which you can at the same time will
that it should become a universal law.' "); see also Heydt, supra note 24 ("The utilitarian
candidate is the principle of utility, which holds that 'actions are right in proportion as they
tend to promote happiness; wrong as they tend to produce the reverse of happiness. By hap-
piness is intended pleasure and the absence of pain .... '.)
236 POZGAR, supra note 35, at 14.
237 See Last Resorts, supra note 11, at 1993 ("For patients who are chronically ill and fac-
ing an imminent risk of death, treatment that palliates severe pain serves the right to die with
dignity . . . ."); see also Heydt, supra note 24, (" 'That the only purpose for which power can
be rightfully exercised over any member of a civilized community, against his will, is to pre-
vent harm to others.' ").
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seeks to adopt or keep, autonomy requires an individual to be free
from constraints including death, pain and suffering, and indignity at
the end of life. 238 As President Obama's administration continues to
impact American culture, patients may finally gain the support they
need to access legal medical marijuana.239 Through the collaborative
efforts of President Obama and Attorney General Eric Holder, the
U.S. Department of Justice will seek criminal charges against medi-
cal marijuana users only when both state and federal laws have been
violated.240 Additionally, medical marijuana clinics will be free of
federal investigations provided their operations are lawful.24 1
As autonomous persons, patients have the right to make deci-
sions regarding their bodies and to seek any and all medical treatment
to alleviate pain and suffering and preserve life.242 This right entitles
a patient to non-interference from people who might attempt to in-
fringe upon these rights and freedom of choice.24 3 Ultimately, a pa-
tient should be free to make medical decisions concerning treatment
and medication that directly impacts his or her own body. In making
decisions concerning a patient's health and well being, patients
should be given the right to access medical marijuana for therapeutic
purposes. By refusing to allow medical marijuana as an alternative
pain treatment, the federal government has infringed upon a patient's
fundamental right of autonomy.
While the federal government should not persecute patients
using medical marijuana for treatment, medical marijuana should be
238 See Planned Parenthood of Se. Pa. v. Casey, 505 U.S. 833, 851 (1992) ("At the heart of
liberty is the right to define one's own concept of existence, of meaning, of the universe, and
of the mystery of human life. Beliefs about these matters could not define the attributes of
personhood were they formed under compulsion of the State.").
239 See Guidelines Released on Medical Marijuana, NATION'S HEALTH, Dec. 1, 2009, at
14, available at 2009 WLNR 26387525 (explaining that law enforcement officials have been
advised "not to arrest or harass medical marijuana patients in states where the practice is le-
gal").
240 See id
241 See id. (" 'These new guidelines effectively open the [sic] door to sensible collabora-
tion between state governments and medical marijuana providers in ensuring that [sic] pa-
tients have safe and reliable access to their medicine ..... ).
242 See Hayry, supra note 18, at 335 ("It could be argued that universal reason ... would
not oppose the use of cannabis, especially if there are good medical grounds for this. Then
autonomy as conformity to the moral law would not require restrictions of freedom as the
non-restriction of options.").
243 See id. ("The most important of these are the right to life, the right to health ... the
ight to bodily integrity .. .. These rights are, essentially, entitlements to non-interference.
Other people should not actively attempt to ... curtail our freedom of choice.").
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carefully regulated and patients should be given access to medical
marijuana in controlled doses under controlled conditions. Like any
medication, marijuana presents its own set of benefits and risks.2 "
While smoking marijuana may not be the safest method to deliver
THC through the body, other methods such as ingesting oral forms of
synthetically government approved THC, for example Marinol, have
their own drawbacks.245 Just like tobacco, smoking marijuana may
require the use of filters to reduce the amount of harmful chemicals
entering the body. Although marijuana should not necessarily be le-
galized across the board, it should be at least removed from Schedule
I to Schedule II. However, the medical marijuana debate will only be
resolved through further government funded, independent research.
244 See Clark, supra note 99, at 40 (explaining that a major criticism of medical marijuana
as an alternative therapy is that it "ha[s] not been scientifically tested; therefore, [its] safety
. .. has been called into question."). However, medical marijuana "can be used to help pa-
tients withstand the effects of accepted treatments." Id.
245 See id. at 43 ("First, some patients have complained that the effects of the pill were too
strong at first, then wore off quickly. Second, Marinol is very expensive, costing about $500
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